Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimsentro-PG2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sentro Pharma & Healthcare

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimsentro-PG2 Tablet SR

Diabetic patients using Glycemia-Control SR tablets, a dual-action formulation, experience improved blood glucose management. This medication, used alongside dietary changes and physical activity, enhances insulin effectiveness in adults with type 2 diabetes, thus reducing blood sugar. Follow your physician's prescribed dosage and regimen. Ingestion with food minimizes digestive discomfort. Missed doses should be taken promptly unless the next dose is imminent; in this case, omit the missed dose. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or meal skipping elevates hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions, pregnancy, or breastfeeding necessitate prior consultation with your doctor, who will assess kidney function before commencing treatment. Limit alcohol consumption to mitigate potential side effects.

Uses of Glimsentro-PG2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimsentro-PG2 Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimsentro-PG2 Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this medication with a meal.

Common Side effects of Glimsentro-PG2 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimsentro-PG2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimsentro-PG2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Glimsentro-PG2 Tablet SR works:

Glimsentro-PG2 SR tablets contain a triple-action formulation of glimepiride, metformin, and pioglitazone, addressing type 2 diabetes when other treatments prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Glimsentro-PG2 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimsentro-PG2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Glimsentro-PG2 tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk with the possibility of infant harm.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimsentro-PG2 Tablet SR cautiously, potentially requiring a modified dosage. Physician consultation is recommended. For individuals with severe kidney disease, Glimsentro-PG2 Tablet SR is contraindicated. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glimsentro-PG2 Tablet SR; dosage modification may be necessary. Consult your physician for guidance. Glimsentro-PG2 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimsentro-PG2 Tablet SR :

Should you forget a Glimsentro-PG2 Tablet SR dose, take it immediately upon remembering. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimsentro-PG2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimsentro-PG2 Tablet SR

Consuming alcohol while taking Glimsentro-PG2 Tablet SR is unsafe. Alcohol can lead to dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Consult your doctor before taking Glimsentro-PG2 Tablet SR if you have congestive heart failure, kidney or liver problems, or eye swelling. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you are taking, including prescription and non-prescription drugs, vitamins, and herbal supplements.
Glimsentro-PG2 Tablet SR, containing metformin, can lead to vitamin B12 deficiency due to its long-term impact on stomach absorption of this vitamin.
Glimsentro-PG2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always keep a readily available fast-acting sugar source, such as candy or chocolate, on hand.
Store this medication in its original, tightly closed container, as directed on the packaging. Dispose of any unused medication. Keep out of reach of children, pets, and others.
Glimsentro-PG2 Tablet SR
159
MRP 194
18% off